Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Squamous Cell Carcinoma of the Oropharynx: early-phase trial registry
2 of 7 indexed Squamous Cell Carcinoma of the Oropharynx trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Squamous Cell Carcinoma of the Oropharynx: 7 US clinical trials tracked, 2 recruiting.
Squamous Cell Carcinoma of the Oropharynx is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Joseph Califano, running 1 of these trials.
Enrollment posture brief
Registry condition squamous-cell-carcinoma-of-the-oropharynx
OPEN 2 | RECR 29% | LATE 0 | EARLY 5 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Squamous Cell Carcinoma of the Oropharynx lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Squamous Cell Carcinoma of the Oropharynx on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Squamous Cell Carcinoma of the Oropharynx is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Squamous Cell Carcinoma of the Oropharynx trials is spread across many organizations.
Joseph Califano accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Squamous Cell Carcinoma of the Oropharynx trials plan to enrol fewer than 100 people.
Median target enrolment is 83 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.
-
Squamous Cell Carcinoma of the Oropharynx research is mostly interventional.
6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
University of Michigan Rogel Cancer Center
NCT05894083
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma
University of Virginia
NCT05962242
Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma
Indiana University
NCT05119036
Safety and Efficacy of APG-157 in Head and Neck Cancer
Aveta Biomics
NCT05312710
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
American College of Radiology
NCT05540899
Saliva-based Detection of CD44
Joseph Califano
NCT03148665
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Galera Therapeutics
NCT01921426
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Squamous Cell Carcinoma of the Oropharynx records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Squamous Cell Carcinoma of the Oropharynx trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Squamous Cell Carcinoma of the Oropharynx page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Squamous Cell Carcinoma of the Oropharynx trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Joseph Califano sponsors the most Squamous Cell Carcinoma of the Oropharynx trials on record, review their full trial history before evaluating a specific study. See Joseph Califano's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Squamous Cell Carcinoma of the Oropharynx condition card totals 7 registered trials; most-linked intervention OncAlert; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.